$982,669,952 in Total Settlement Funds Available. See if you qualify!Find Out More

Novo Nordisk A/S Settlement
(NYSE: NVO)
Settlement

Claim Deadline: July 27, 2022

Settlement Fund: $100,000,000

Settlement Class

All persons or entities that purchased the American Depositary Receipts (“ADRs”) of Novo Nordisk A/S (“Novo Nordisk” or the “Company”) between February 3, 2015 and February 2, 2017, inclusive.

Important Documents

Settlement Status

Disbursed

Class Period

February 03, 2015 - May 02, 2017

Settlement Hearing Date

June 27, 2022

Opt-Out Deadline

October 13, 2020

Claims Admin

JND Legal Administration
Novo Nordisk Securities Litigation
c/o JND Legal Administration
P.O. Box 91154
Seattle, WA 98111
+1 833-674-0167
info@NovoNordiskSecuritiesLitigation.com

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.